Tech Company Financing Transactions

InterVenn BioSciences Funding Round

On 8/3/2021, InterVenn BioSciences raised $201 million in Series C funding from Heritage Provider Network, Highside Capital Management and Irving Investors.

Transaction Overview

Company Name
InterVenn BioSciences
Announced On
8/3/2021
Transaction Type
Venture Equity
Amount
$201,000,000
Round
Series C
Investors

Heritage Provider Network (Lead Investor)

Highside Capital Management (Lead Investor)

Irving Investors (Lead Investor)

SoftBank Group (Lead Investor)

Amplify Partners

Anzu Partners (David Michael)

Genoa Ventures (Jenny Rooke)

True Ventures

Proceeds Purpose
The company intends to use the funds to accelerate development and commercialization of Dawn�, a liquid biopsy assay for immune checkpoint inhibitor response prediction, and to expand the network of partners on its AI-driven glycoproteomics platform to accelerate development and commercialization of new clinical solutions, and broaden insights into new biomarkers and therapies.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
2 Tower Pl. 5th Floor
San Francisco, CA 94080
USA
Phone
(888) 706-1670
Website
www.intervenn.bio
Email Address
[email protected]
Overview
InterVenn BioSciences aims to find solutions for the most challenging health problems. InterVenn's approach combines the analysis of glycoproteomics using mass spectrometry with data science and artificial intelligence to quickly identify potentially actionable and clinically relevant information for conditions including cancers, autoimmunity, fibrosis, and neurodegeneration.
Profile
InterVenn BioSciences LinkedIn Company Profile
Social Media
InterVenn BioSciences Company Twitter Account
Company News
InterVenn BioSciences News
Facebook
InterVenn BioSciences on Facebook
YouTube
InterVenn BioSciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Aldo Carrascoso
  Aldo Carrascoso LinkedIn Profile  Aldo Carrascoso Twitter Account  Aldo Carrascoso News  Aldo Carrascoso on Facebook
Chief Information Officer
Randolph Barr
  Randolph Barr LinkedIn Profile  Randolph Barr Twitter Account  Randolph Barr News  Randolph Barr on Facebook
Chief Operating Officer
Erwin Estigarribia
  Erwin Estigarribia LinkedIn Profile  Erwin Estigarribia Twitter Account  Erwin Estigarribia News  Erwin Estigarribia on Facebook
Chief Scientific Officer
Klaus Lindpaintner
  Klaus Lindpaintner LinkedIn Profile  Klaus Lindpaintner Twitter Account  Klaus Lindpaintner News  Klaus Lindpaintner on Facebook
General Manager
Axel Kornerup
  Axel Kornerup LinkedIn Profile  Axel Kornerup Twitter Account  Axel Kornerup News  Axel Kornerup on Facebook
Vice President
Kaitlynn Moser
  Kaitlynn Moser LinkedIn Profile  Kaitlynn Moser Twitter Account  Kaitlynn Moser News  Kaitlynn Moser on Facebook
Vice President
Daniel Serie
  Daniel Serie LinkedIn Profile  Daniel Serie Twitter Account  Daniel Serie News  Daniel Serie on Facebook
Vice President
Ada Wong
  Ada Wong LinkedIn Profile  Ada Wong Twitter Account  Ada Wong News  Ada Wong on Facebook
VP - Bus. Development
Fadzhairi Jabar
  Fadzhairi Jabar LinkedIn Profile  Fadzhairi Jabar Twitter Account  Fadzhairi Jabar News  Fadzhairi Jabar on Facebook
VP - Bus. Development
John Leite
  John Leite LinkedIn Profile  John Leite Twitter Account  John Leite News  John Leite on Facebook
VP - General Counsel
Stephana Patton
  Stephana Patton LinkedIn Profile  Stephana Patton Twitter Account  Stephana Patton News  Stephana Patton on Facebook
VP - R & D
Xin Cong
  Xin Cong LinkedIn Profile  Xin Cong Twitter Account  Xin Cong News  Xin Cong on Facebook
VP - Regulatory Affairs
Katherine Dalao
  Katherine Dalao LinkedIn Profile  Katherine Dalao Twitter Account  Katherine Dalao News  Katherine Dalao on Facebook

 

 

Browse more venture capital transactions:

Prev: 8/3/2021: Finite State venture capital transaction
Next: 8/3/2021: reThought Insurance venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.